Myhre syndrome
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Myhre syndrome | |
|---|---|
| |
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Short stature, hearing loss, intellectual disability, joint stiffness, heart defects |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the SMAD4 gene |
| Risks | |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Lujan–Fryns syndrome, Marfan syndrome, Loeys–Dietz syndrome |
| Prevention | |
| Treatment | Symptomatic and supportive |
| Medication | |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | |
Myhre Syndrome is a rare genetic disorder characterized by distinctive facial features, hearing loss, and musculoskeletal abnormalities. It is caused by mutations in the SMAD4 gene and is inherited in an autosomal dominant manner.
Symptoms and Signs[edit]
Patients with Myhre Syndrome typically present with a variety of symptoms, including:
- Facial dysmorphism: Distinctive facial features such as a square-shaped face, deep-set eyes, and a small mouth.
- Hearing loss: Progressive sensorineural hearing loss is common.
- Musculoskeletal abnormalities: These include limited joint mobility, thick skin, and muscle hypertrophy.
- Cardiovascular disease: Many patients develop cardiovascular problems, including hypertension and pulmonary stenosis.
- Intellectual disability: Some patients may have mild to moderate intellectual disability.
Diagnosis[edit]
The diagnosis of Myhre Syndrome is based on clinical features and confirmed by genetic testing showing a mutation in the SMAD4 gene.
Treatment[edit]
There is no cure for Myhre Syndrome. Treatment is symptomatic and supportive, and may include physical therapy for joint stiffness, hearing aids for hearing loss, and regular monitoring for cardiovascular disease.
Prognosis[edit]
The prognosis for individuals with Myhre Syndrome varies. Some individuals may have a normal lifespan, while others may have life-threatening complications due to cardiovascular disease.
See Also[edit]
References[edit]
<references />
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
